CHONGQING GENRIX BIOPHARMACEUTICAL financial statements, including revenue, expenses, and profit

The total revenue of 688443 for the last quarter is 17.61 M CNY, and it's 49.48% higher compared to the previous quarter. The net income of Q4 24 is -254.10 M CNY.